🎉 Free to use until Sep 16, 2026 — try it out for our launch!
STOCKIQAISTOCKIQAI
עברית
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.15▼ 4.17%
TA-125₪4,032.47▲ 0.23%
S&P 5007,709.96▼ 0.18%
Dow Jones53,885.1▼ 0.85%
Nasdaq26,348.35▼ 0.06%
Russell 20003,001.55▼ 0.58%
Fear Index (VIX)15.15▼ 4.17%
TA-125₪4,032.47▲ 0.23%

TEM

Tempus AI, Inc. - Class A Common Stock

Technology · ·

$46.12

▼ $0.58 (-1.2%)

Market Cap

—

Day Range

$44.80 - $46.75

52-Week Range

$40.77 - $104.32

Beta

—

Next Earnings

29.10.2026

TEM is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.

🏢 Similar Stocks in the Same Sector

AAOI

Applied Optoelectronics, Inc.

AAPL

Apple Inc.

ABTC

American Bitcoin Corp.

-17.2% (1Y)

Investor Score
42/ 100D
🔴 Weak

This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer

📈26FTechnical
💰25FFundamental
🚀68B-Growth
💎38FValuation
📰68B-News
🏦58CQuality
⚠️48D+Risk

Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%

🔍 Cross-Check

Overall Score

🔴 Bearish

Technical Trend

🔴 Bearish

Insiders

🔴 Bearish

✅ Why is the score relatively high?

  • 🟢 Revenue growth (last year): 83.4%
  • 🟢 Earnings per share (EPS) growth: 77.4%
  • 🟢 Net income growth: 65.3%
  • 🟢 Operating margin is stable or improving over time
  • 🟢 Current ratio: 3.13

⚠️ What's concerning?

  • 🔴 Estimated fair value: -$35,015.09 vs. price $46.12 (-76021.7%)
  • 🔴 Operating margin: -19.9% (negative)
  • 🔴 Net margin: -19.3% (negative)
  • 🔴 ATR: 7.1% of price
  • 🔴 Return on equity (ROE): -49.9% (negative)

🚦 Quality & Risk Checks

🟢 Operating margin stability🔴 Daily volatility (ATR)🟢 Liquidity risk

📰 News Trend

Based on real financial news (Finnhub)
🟡 Mixed

Everyone's writing about Tempus AI, Inc. - Class A Common Stock. News trend score: 68. Reason: 9 of the last 19 articles are positive, versus 6 negative.

🟢 Caris Life Sciences: Guidance Raised, Valuation Still Attractive — SeekingAlpha🟢 CellCarta To Include Tempus In CDx Commercialization Lab Network As Network's Second Commercial Laboratory Partner, Enhancing Oncology Companion Diagnostics For Biopharma — Benzinga🟢 The BioRevolution Has Accelerated — SeekingAlpha

News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer

📈 Technical Analysis

Based on the last 252 trading days, calculated from real price data. Click an indicator for details and a chart.

🔴 Most indicators support a downtrend (1 bullish · 7 bearish · 2 neutral)

Conclusions

  • 🔴Price vs. SMA 50 — Price is below the 50-day average
  • 🔴Price vs. SMA 200 — Price is below the 200-day average
  • 🔴MACD — MACD histogram is negative — falling momentum
  • 🔴RSI — RSI 43.4 — weak/negative bias
  • 🟡Stochastic — %K 56.2 — neutral range
  • 🟡ADX (trend strength) — ADX 23.2 — weak trend/choppy
  • 🔴Relative strength vs. S&P 500 — -18.8% over the last 3 months relative to the index
  • 🔴ROC (rate of change) — ROC 12 days: -6.2%
  • 🟢Parabolic SAR — Price is above the SAR point — uptrend
  • 🔴CMF (money flow) — CMF 20 days: -0.08

Wyckoff Method Analysis

A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.

Markdown

The stock is in a clear downtrend with no defined trading range in the period examined.

High confidence

Evidence Behind This Read

  • 🔴Falling price trend — A -2.6% change over the last 50 days, with no defined trading range.

The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.

🎯 Trade Planning (M.A.E.E Framework)

Based on a mechanical trading method: market structure → value zone → ATR-based exit point. Not investment advice — a calculation tool only.

1️⃣ Market Structure

🔴 Downtrend

The price is below the 200-day average — an environment that mainly favors looking for selling (Short) opportunities, not buying.

2️⃣ Value Zone

🟡 Price far from value zone

The price is currently far from the 50-day average — the method recommends waiting for a "pullback" before entering, rather than chasing prices.

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = resistance plusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Entry

$45.96

Stop-Loss

$66.38

Risk per Share

$20.42

Direction

Short

Profit Targets by Risk/Reward Ratio (R)

1:2 R

$5.12

1:3 R

-$15.30

1:5 R

-$56.13

💰 Position Size Calculator

A core principle of the method: never risk a fixed dollar amount — risk a fixed percentage of equity, and let the position size vary according to the risk per share.

Suggested Position Size

4 sh.

💰 Financial Health

Profitability

Gross Margin

—

Operating Margin

-19.9%

Net Margin

-19.3%

EBITDA Margin

-19.9%

Efficiency

ROE

-49.9%

ROA

-10.8%

ROIC

—

EPS

-$1.41

Balance Sheet

Cash

$604.79M

Total Debt

—

Current Ratio

3.13

Debt/Equity

—

Conclusions

  • 🔴Operating margin — Operating margin: -19.9% (negative)
  • 🔴Net margin — Net margin: -19.3% (negative)
  • 🔴Return on equity (ROE) — Return on equity (ROE): -49.9% (negative)
  • 🔴Return on assets (ROA) — Return on assets (ROA): -10.8% — weak
  • 🟢Current ratio (liquidity) — Current ratio: 3.13
  • 🔴Interest coverage — Interest coverage: -3.6x

🚀 Growth

Revenue

Earnings per Share (EPS)

Net Income

Free Cash Flow (FCF)

Conclusions

  • 🟢Revenue growth (last year) — Revenue growth (last year): 83.4%
  • 🟢Earnings per share (EPS) growth — Earnings per share (EPS) growth: 77.4%
  • 🔴Free cash flow growth — Free cash flow growth: -13.2%
  • 🟢Net income growth — Net income growth: 65.3%

💎 Fair Value (Valuation)

Current Price

$46.12

Estimated Fair Value (DCF)

-$35,015.09

Gap

-76021.7%

🔴 Appears expensive relative to estimated value

Show all model (DCF) assumptions →

Year 1 Growth Rate

25.0%

Discount Rate (WACC)

9.0%

Terminal Growth Rate

2.5%

Projection Years

5

YearGrowth RateProjected FCFPresent Value
125.0%$-298.92M$-274.24M
219.4%$-356.84M$-300.35M
313.8%$-405.91M$-313.43M
48.1%$-438.89M$-310.92M
52.5%$-449.86M$-292.38M

Base FCF (last actual year)

$-239.14M

Terminal Value

$-7.09B

Present Value of Terminal Value

$-4.61B

Enterprise Value

$-6.10B

Net Debt

$0

Equity Value

$-6.10B

*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.

Book Value per Share

$2,819.43

Tangible Book Value per Share (Tangible NAV)

-$1,917.42

Conclusions

  • 🔴DCF Fair Value — Estimated fair value: -$35,015.09 vs. price $46.12 (-76021.7%)
  • 🟡Tangible Net Asset Value (NAV) — NAV per share: -$1,917.42
  • 🟡P/E — P/E: -32.6

🕴️ Insider Trading

Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 23 sales out of the last 25 filings.

NameTransaction TypeDateSharesChangePrice
Polovin AndrewGrant/Award from Employer29.7.2026168,215+40,000—
Rogers James WilliamGrant/Award from Employer29.7.2026154,866+40,000—
LEFKOFSKY ERIC POpen Market Sale28.7.20268,754,811-20,472$41.34
LEFKOFSKY ERIC POpen Market Sale28.7.20268,723,905-30,906$42.36
LEFKOFSKY ERIC POpen Market Sale28.7.20268,717,783-6,122$42.95
LEFKOFSKY ERIC POpen Market Sale28.7.202615,342,403-48,066$41.34
LEFKOFSKY ERIC POpen Market Sale28.7.202615,269,843-72,560$42.36
LEFKOFSKY ERIC POpen Market Sale28.7.202615,255,469-14,374$42.95
LEFKOFSKY ERIC POpen Market Sale28.7.2026829,460-2,671$41.34
LEFKOFSKY ERIC POpen Market Sale28.7.2026825,429-4,031$42.36
LEFKOFSKY ERIC POpen Market Sale28.7.2026824,631-798$42.95
LEFKOFSKY ERIC POpen Market Sale28.7.2026232,199-17,801$41.34
LEFKOFSKY ERIC POpen Market Sale28.7.2026205,324-26,875$42.36
LEFKOFSKY ERIC POpen Market Sale28.7.2026200,000-5,324$42.95
Fukushima RyanOpen Market Sale8.7.2026187,063-13,984$56.80
Fukushima RyanOpen Market Sale8.7.2026173,377-13,686$57.37
Fukushima RyanOpen Market Sale8.7.2026169,900-3,477$58.55
Fukushima RyanOpen Market Sale8.7.2026167,763-2,137$59.47
Fukushima RyanOpen Market Sale6.7.2026201,047-10,000$60.00
LEFKOFSKY ERIC POpen Market Sale29.6.20268,806,216-2,317$55.38
LEFKOFSKY ERIC POpen Market Sale29.6.20268,796,786-9,430$56.51
LEFKOFSKY ERIC POpen Market Sale29.6.20268,786,493-10,293$57.13
LEFKOFSKY ERIC POpen Market Sale29.6.20268,784,413-2,080$58.30
LEFKOFSKY ERIC POpen Market Sale29.6.20268,775,283-9,130$59.23
LEFKOFSKY ERIC POpen Market Sale29.6.202615,514,198-9,271$55.38

📉 Short Interest

Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.

Monthly Trend — Open Short Interest

↓-9.6%

30,360,084 shares short as of 2026-07-15 · vs. 33,602,707 on 2026-06-30

Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.

Weekly Trend — Daily Short-Sale Activity

↓-5.5%

50.4% of trading volume this week was short selling, vs. 53.3% the prior week

Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.

📰 News & Sentiment

Sentiment based on basic keywords (not AI) — 9 positive, 4 neutral, 6 negative out of the last 19 articles.